Zobrazeno 1 - 10
of 27
pro vyhledávání: '"A. S. Semikhin"'
Autor:
T. N. Demidova, L. V. Rubis, A. S. Semikhin, E. A. Gurina, A. V. Amirkhanyan, N. V. Sheenkov, V. V. Gorshenko, Yu. A. Birkovskay
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 22, Iss 6, Pp 175-182 (2024)
Tularemia is a natural focal infection, characterized by the ability to maintain epizootic and epidemic potential for decades and periodically become more active. Since 2016, an increase in the incidence of tularemia has been observed in the Republic
Externí odkaz:
https://doaj.org/article/1ee88c040394458e976679d7ac02f439
Autor:
N. V. Bashmakova, E. N. Novoselova, T. A. Nazarenko, M. M. Ovchinnikova, Yu. A. Fetisova, E. V. Gergert, M. A. Ganikhina, N. G. Valiullina, E. O. Golovina, M. R. Shcherban, A. S. Semikhin, M. A. Polzikov, D. V. Blinov
Publikováno v:
Акушерство, гинекология и репродукция, Vol 17, Iss 6, Pp 680-706 (2024)
Introduction. Approaches to treatment of infertility have been progressively updated because the field of assisted reproductive technologies (ART) is a science-based symbiosis of the latest knowledge and advances in medicine, biology, and genetics. T
Externí odkaz:
https://doaj.org/article/60acf364c22b403e92c6aedd4a42ccf1
Publikováno v:
Фармакоэкономика, Vol 16, Iss 1, Pp 49-59 (2023)
Objective: to perform a clinical and economic analysis of using drugs containing follitropin alfa as an active substance and to assess the impact of the studied drugs on the budget of the state healthcare system of the Russian Federation considering
Externí odkaz:
https://doaj.org/article/c1c77c5573c2494d8024df3e54621ad4
Autor:
T. V. Mikhailova, L. G. Emelyanova, Y. S. Podobedova, T. N. Demidova, M. I. Kormilitsyna, A. S. Semikhin, A. V. Amirkhanyan, N. E. Sharapova, O. V. Savelyeva, Y. V. Popova
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 21, Iss 4, Pp 60-69 (2022)
Relevance. Combined foci of zoonotic infections are found in all regions of the Russian Federation. A feature of combined foci is the common biocenosis for populations of pathogens of various etiologies (bacteria, viruses, parasitic infections) and t
Externí odkaz:
https://doaj.org/article/3b8b36fab6a441d89a08362255433396
Publikováno v:
Акушерство, гинекология и репродукция, Vol 11, Iss 3, Pp 116-126 (2017)
Within the framework of the 27th international conference «Reproductive technologies today and tomorrow», the first Russia-made follitropin alfa biosimilar for controlled ovarian stimulation in assisted reproductive technologies (ART) was presented
Externí odkaz:
https://doaj.org/article/9868f7cbaacd40ca9130b04658c9f24e
Autor:
M. Z. Fedorova, S. V. Nadezhdin, A. S. Semikhin, M. A. Lazebnaya, G. V. Khramov, Y. R. Kolobov, A. V. Gromov, M. S. Bartov, V. G. Lunin, A. S. Karyagina, D. V. Gunderov
Publikováno v:
Travmatologiâ i Ortopediâ Rossii, Vol 0, Iss 2, Pp 101-106 (2011)
The influence of both, the composite material based on the protein-mineral components including the prolonged form of the recombinant human bone morphogenetic protein 2 (rhBMP-2) and the method of the titanium implant’s surface treatment, on the re
Externí odkaz:
https://doaj.org/article/d763ae5699894f12911224b430652468
Autor:
Amir I. Tukhvatulin, Inna V. Dolzhikova, Dmitry V. Shcheblyakov, Olga V. Zubkova, Alina S. Dzharullaeva, Anna V. Kovyrshina, Nadezhda L. Lubenets, Daria M. Grousova, Alina S. Erokhova, Andrei G. Botikov, Fatima M. Izhaeva, Olga Popova, Tatiana A. Ozharovskaia, Ilias B. Esmagambetov, Irina A. Favorskaya, Denis I. Zrelkin, Daria V. Voronina, Dmitry N. Shcherbinin, Alexander S. Semikhin, Yana V. Simakova, Elizaveta A. Tokarskaya, Maksim M. Shmarov, Natalia A. Nikitenko, Vladimir A. Gushchin, Elena A. Smolyarchuk, Tatiana G. Zubkova, Konstantin A. Zakharov, Vasiliy B. Vasilyuk, Sergei V. Borisevich, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
The Lancet Regional Health. Europe, Vol 11, Iss , Pp 100241- (2021)
Background: While the world is experiencing another wave of COVID-19 pandemic, global vaccination program is hampered by an evident shortage in the supply of licensed vaccines. In an effort to satisfy vaccine demands we developed a new single-dose va
Externí odkaz:
https://doaj.org/article/54fc97d8b69745aa9da8b8b6bf909e3d
Autor:
Eugene I Gusev, Mikhail Yu Martynov, Alexey A Nikonov, Nikolay A Shamalov, Michail P Semenov, Eugene A Gerasimets, Elena B Yarovaya, Andrey M Semenov, Alexander I Archakov, Sergey S Markin, Sergey B Aksentiev, Denis S. Yunevich, Andrey M Alasheev, Olga V Androfagina, Vladimir V Bobkov, Ksenia V Choroshavina, Janna Yu Chefranova, Yuriy A Lykov, Svetlana E Chuprina, Andrey A Vorobev, Alexey V Dobrovolskiy, Ulukpan A Elemanov, Sergey A Fedaynin, Vladimir I Gorbachev, Ivan V Korobeinikov, Irina V Greshnova, Larisa L Korsunskaya, Anastasiya A Nikonova, Vasily A Kudinov, Rafael I Artyushev, Vladimir A Kutsenko, Valentina N Nesterova, Alexey A Nizov, Alexey I Girivenko, Alexey A Orlovsky, Eduard A Ponomarev, Dmitriy V Popov, Sergey A Pribylov, Alexander S Semikhin, Ludmila V Timchenko, Olga N Jadan, Sergey A Zakharov, Alexander N Chirkov, Natalya V Zhukovskaya
Publikováno v:
The Lancet Neurology. 20:721-728
Summary Background Non-immunogenic staphylokinase is modified recombinant staphylokinase with low immunogenicity, high thrombolytic activity, and selectivity to fibrin. We aimed to assess the safety and efficacy of a single intravenous bolus of non-i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ce875c314c297bce445455e2b16b79b
https://doi.org/10.1016/s1474-4422(21)00210-6
https://doi.org/10.1016/s1474-4422(21)00210-6
Autor:
D. A. Kleymenov, Anna V. Kovyrshina, Nadezhda L. Lubenets, Natalia A. Nikitenko, Sergei V. Borisevich, Alexander S. Semikhin, Elizaveta A. Tokarskaya, Daria M. Grousova, Andrey Pochtovyi, M M Shmarov, Dmitry V. Shcheblyakov, Olga Popova, Shchetinin Am, Tatiana A Ozharovskaya, Andrey Komissarov, Evgeniia N. Bykonia, Alina S. Dzharullaeva, Dmitry Lioznov, Alexander L. Gintsburg, Artem P. Tkachuk, A. I. Tukhvatulin, Denis Y. Logunov, Nadezhda P. Kuznetsova, Liubov I. Popova, Olga V. Zubkova, Inna V. Dolzhikova, Lyudmila Vasilchenko, Elena V. Shidlovskaya, Alina S. Erokhova, E. P. Mazunina, Boris S. Naroditsky, Alexander Tsybin, Elizaveta V. Divisenko, Vladimir A. Gushchin, Daria Danilenko, Fatima M. Izhaeva
ObjectivesVaccination remains the most effective response to the COVID-19 pandemic. Most vaccines use two-dose regimens. In turn, single-dose vaccines also have high potential, since, on the one hand, they simplify the vaccination program, make it mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f145807fe93e4a55dadded1a8a6b758
https://doi.org/10.1101/2021.10.08.21264715
https://doi.org/10.1101/2021.10.08.21264715
Autor:
A. I. Tukhvatulin, Fatima M. Izhaeva, Denis Y. Logunov, Daria A. Egorova, Daria M. Grousova, Andrei G. Botikov, Alina S. Dzharullaeva, Sergei V. Borisevich, Olga Popova, Denis I. Zrelkin, Ilias B Esmagambetov, Alexander S. Semikhin, Daria V Voronina, Elena A Smolyarchuk, Dmitry N. Shcherbinin, Olga V. Zubkova, Nadezhda L. Lubenets, M M Shmarov, Anna V. Kovyrshina, Tatiana A Ozharovskaya, Boris S. Naroditsky, Dmitry V. Shcheblyakov, Inna V. Dolzhikova, Alexander L. Gintsburg, Irina A Favorskaya, Alina S. Erokhova, Natalia A. Nikitenko, Vladimir A. Gushchin, Sergey Zyryanov, Yana V. Simakova, Elizaveta A. Tokarskaya
Publikováno v:
The Lancet
Lancet (London, England)
Lancet (London, England)
Background A heterologous recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac (Sputnik V), showed a good safety profile and induced strong humoral and cellular immune responses in participants in phase 1/2 clinical trials. Here, we report preli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45be4c8958b8b211911b441dc840d66e